GPX4 and ovarian carcinoma: Tripterygium glycosides, by targeting the NRF2/GPX4 signal axis, disrupt the stability of the oxidation restoration reaction and induce ferroptosis in ovarian tumor cells, thereby enhancing the chemical susceptibility of ovarian cancer to cisplatin (39).